
Duomed Group
Provides total solutions and offers innovative breakthrough product.
Date | Investors | Amount | Round |
---|---|---|---|
investor investor | €0.0 | round | |
* | N/A | Acquisition | |
Total Funding | 000k |
EUR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | (10 %) | (21 %) | 11 % | (19 %) | 113 % | 85 % | 43 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | 19 % | 10 % | 19 % | 12 % | 22 % | - | - |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | 9 % | 2 % | 10 % | 3 % | 13 % | - | - |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article, Dealroom estimates
Related Content
Duomed Group is a comprehensive solution provider specializing in innovative medical products and services. Operating primarily in the Benelux region, Duomed serves a wide range of clients within the healthcare sector, including hospitals, clinics, and medical professionals. The company focuses on delivering high-quality, breakthrough medical solutions that enhance the quality, continuity, and safety of healthcare processes. Duomed's business model revolves around selling, installing, integrating, and maintaining advanced medical technologies. Revenue is generated through the sale of these products and the provision of ongoing support and maintenance services. By leveraging local expert teams, Duomed ensures that its solutions are seamlessly integrated into high-tech, critical medical environments, thereby optimizing operational excellence.
Keywords: medical solutions, healthcare, Benelux, hospitals, clinics, innovation, quality, continuity, safety, operational excellence.
Tech stack
Investments by Duomed Group
Edit


